A multi-center, Randomized controlled trial of a group psychological intervention for psychosis with comorbid cannabis dependence over the early course of illness

Schizophrenia Research

Volumn 143, Issue 1, 2013, Pages 138-142

  Madigan, Kevin ^a,b   Brennan, Daria ^a,b   Lawlor, Elizabeth ^a,b   Turner, Niall ^a,b   Kinsella, Anthony ^b,c   O'Connor, John J ^d   Russell, Vincent ^e,f   Waddington, John L ^c,e   O'Callaghan, Eadbhard ^a,b  

^a Cluain Mhuire Family Centre   (Ireland)

^b DETECT   (Ireland)

^c ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^d Drug Treatment Centre Board   (Ireland)

^e CAVAN GENERAL HOSPITAL   (Ireland)

^f BEAUMONT HOSPITAL   (Ireland)

Author keywords

Psychological therapy; Psychosis; RCT; Substance abuse

Indexed keywords

ADULT; ARTICLE; CANNABIS ADDICTION; COGNITIVE THERAPY; COMORBIDITY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; GROUP THERAPY; HEALTH BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL FUNCTION; MOTIVATIONAL INTERVIEWING; MULTICENTER STUDY; PRIORITY JOURNAL; PSYCHOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; AGE FACTORS; ANALYSIS OF VARIANCE; ATTITUDE; COGNITIVE THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MARIJUANA ABUSE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; QUALITY OF LIFE; RECURRENCE; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84871938589     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2012.10.018     Document Type: Article

References (37)

1. Addington D., Addington J., Schissel B. A depression rating scale for schizophrenics. Schizophr. Res. 1990, 3:247-251.
2. Addington D., Addington J., Maticka-Tyndale E., Joyce J. Reliability and validity of a depression rating scale for schizophrenics. Schizophr. Res. 1992, 6:201-208.
3. Andreasen N.C. The Scale for Assessment of Negative Symptoms (SANS) 1983, University of Iowa.
4. Andreasen N.C. The Scale for Assessment of Positive Symptoms (SAPS) 1984, University of Iowa.
5. Barrowclough C., Haddock G., Tarrier N., Lewis S.W., Moring J., O'Brien R., et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with co-morbid schizophrenia and substance use disorders. Am. J. Psychiatry 2001, 158:1706-1713.
6. Barrowclough C., Haddock G., Lobban F., Jones S., Siddle R., Roberts C., Gregg L. Group-cognitive behavioural therapy for schizophrenia. Randomised controlled trial. Br. J. Psychiatry 2006, 189:527-532.
7. Barrowclough C., Haddock G., Wykes T., Beardmore R., Conrod P., Craig T., et al. Integrated motivational interviewing and cognitive behavioral therapy for people with psychosis and comorbid substance misuse: randomized controlled trial. BMJ 2010, 341:c6325.
8. Beiser M., Erickson D., Fleming J.A., Iacono W.G. Establishing the onset of psychotic illness. Am. J. Psychiatry 1993, 150:1349-1354.
9. Bellack A., Bennett M., Gearon J., Brown C., Yang Y. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness. Arch. Gen. Psychiatry 2006, 63:426-432.
10. Birchwood M., Drury V., Healy J., Macmillan F., Slade M. A self-report insight scale for psychosis: reliability, validity and sensitivity to change. Acta Psychiatr. Scand. 1994, 89:62-67.
11. Buckley P.F., Miller B.J., Lehrer D.S., Castle D.J. Psychiatric comorbidities and schizophrenia. Schizophr. Bull. 2009, 35:383-402.
12. Claussen B. Alcohol disorders and re-employment in a 5 year follow up of long term employment. Addiction 1999, 94:133-138.
13. Cleary M., Hunt G.E., Matheson S.L., Siegfried N., Walter G. Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database Syst. Rev. 2008, Issue 1. Art. No.: CD001088. http://dx.doi.org/10.1002/14651858.CD001088.pub2.
14. Compton M.T., Furman A.C., Kaslow N.J. Negative symptom scores among cannabis dependant with schizophrenia spectrum disorders: preliminary evidence from an African-American first episode sample. Schizophr. Res. 2004, 71:61-64.
15. Drake R.E., Osher F.C. Homelessness and dual diagnosis. Am. Psychol. 1991, 46:1149-1158.
16. Edwards J., Elkins K., Hinton M., Harrigan S., Donovan K., Athanasopolulos O., et al. Randomized controlled trial of a cannabis-focused intervention for young people with first episode psychosis. Acta Psychiatr. Scand. 2006, 114:109-117.
17. Endicott J., Spitzer R.L., Fleiss J.L., Cohen J. The Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance. Arch. Gen. Psychiatry 1976, 33:97-100.
18. First M., Spitzer R., Williams J., Gibbon M. Structured Clinical Interview for DSM-IV (SCID-I) Research Version 1995, Biometrics Research, New York Psychiatric Institute.
19. Haddock G., Barrowclough C., Tarrier N., Moring J., O'Brien R., Schofield N., et al. Cognitive-behavioral therapy and motivational intervention for schizophrenia and substance misuse: 18 month outcomes of a randomized controlled trial. Br. J. Psychiatry 2003, 183:418-426.
20. Hogan T.P., Awad A.G., Eastwood R.A. A self report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol. Med. 1983, 13:177-183.
21. Isaac M., Isaac M., Holloway F. Is cannabis an antipsychotic? The experience in psychiatric intensive care. Hum. Psychopharmacol. 2005, 20:207-210.
22. Kamali M., Kelly L., Gervin M., Browne S., Larkin C., O' Callaghan E. Insight and comorbid substance misuse and medication compliance among patients with schizophrenia. Psychiatr. Serv. 2001, 52:161-166.
23. Kessler R.C. The national comorbidity survey, preliminary results and future directions. Int. J. Methods Psychiatr. Res. 1995, 5:139-151.
24. Koskinen J., Lohonen J., Koponen H., Ioshanni M., Miettunen J. Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis. Schizophr. Bull. 2010, 36:1115-1130.
25. Large M., Sharma S., Compton M.T., Slade T., Nielssen O. Cannabis use and earlier onset of psychosis: systematic meta-analysis. Arch. Gen. Psychiatry 2011, 68:555-561.
26. Machielson M., Van Der Sluis S., De Han L. Cannabis use in patients with a first episode psychosis and subjects at ultra-high risk of psychosis: impact on psychotic and pre-psychotic symptoms. Aust. N. Z. J. Psychiatry 2010, 44:721-728.
27. Malla A.K., Norman R.M., Williamson P. Stability of positive and negative symptoms in schizophrenia. Can. J. Psychiatry 1993, 38:617-621.
28. Mclellan A.T., Luberosky L., Woody G.E., O'Brien C.P. An improved diagnostic evaluation instrument for substance abuse patients: the addiction severity index. J. Nerv. Ment. Dis. 1980, 168:26-33.
29. Melle I., Haahr U., Friis S., Hustoft K., Johannessen J.O., Larsen T.K., et al. Reducing the duration of untreated first-episode psychosis - effects on baseline social functioning and quality of life. Acta Psychiatr. Scand. 2005, 112:469-473.
30. Miller W.R., Rollnick S. Motivational Interviewing: Preparing People to Change Addictive Behavior 1991, The Guilford Press.
31. Miller R., Ream G., Mc Cormac J., Gunduz-Bruce H., Sevey S., Robinson O. A prospective study of cannabis use as a risk factor for non-adherence and treatment dropout in first episode schizophrenia. Schizophr. Res. 2009, 113:138-144.
32. Moore T., Zammit S., Lingford-Hughes A., Barnes T., Jones P., Burke M. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007, 370:319-328.
33. Norman R., Malla A.K., Cortese L., Diaz F. A study of the interrelationship between and the comparative interrater reliability of SAPS, SANS and PANSS. Schizophr. Res. 1996, 19:73-85.
34. Patterson D.A., Lee M.S. Field trial of the global assessment of functioning modified. Am. J. Psychiatry 1995, 152:1386-1388.
35. Skevington S.M., Lofty M., O'Connell K.A. The WHOQOL-BREF quality of life assessment; psychometric properties and results of the international field trial: a report from the WHOQOL group. Qual. Life Res. 2004, 13:299-310. Who-QOL Group.
36. Wade D., Harrigan S., Edwards S., Burgess P.M., Whelan G., Mcgorry P.D. Course of substance misuse and daily tobacco use in first episode psychosis. Schizophr. Res. 2006, 81:145-150.
37. Zanis D.A., Mclellan A.T., Corse S. Is the Addiction Severity Index a reliable and valid instrument among clients with severe and persistent mental illness and substance abuse disorders?. Community Ment. Health J. 1997, 33:213-227.